We previously reported that TNFR1‐KO mice were protected from the development of hypertension, cardiac hypertrophy, remodeling, and dysfunction after 1‐week Ang‐II infusion (Duerrschmid et al. The gene discussed is AGT; the disease is cardiac hypertrophy.